GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

In October, the FDA removed Mounjaro and Zepbound—the diabetes and obesity GLP-1 drugs made by Eli Lilly—from the shortage ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Here is a list of commonly prescribed GLP-1 medications: GLP-1 medications offer a range of potential health benefits, specifically for those with type 2 diabetes or those looking to lose weight.

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications primarily used to treat type 2 diabetes. GLP-1s work by regulating the production of insulin and lowering your blood sugar.

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...